Open AccessCombination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells
Author(s) -
Suhong Chen,
Dandan Xu,
Pengjun Zhou,
Yao Wang,
Qiuying Liu,
Zhe Ren,
Zhong Liu,
Xia Wang,
Huiqing Huang,
Xue Xue,
Ying Wang,
Yifei Wang
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11156
Subject(s) - sorafenib , liver cancer , hepatocellular carcinoma , cancer research , cancer , cancer cell , apoptosis , oncogene , cell growth , medicine , combination therapy , cell cycle , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom